e-learning
resources
Paris 2018
Monday, 17.09.2018
News on the diagnosis of idiopathic interstitial pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Breath Biomarkers in Idiopathic Pulmonary Fibrosis: A Systematic Review
C. Hayton (Manchester, United Kingdom), D. Terrington (Norwich, United Kingdom), A. Wilson (Norwich, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), C. Leonard (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom)
Source:
International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Session:
News on the diagnosis of idiopathic interstitial pneumonia
Session type:
Thematic Poster
Number:
2921
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Hayton (Manchester, United Kingdom), D. Terrington (Norwich, United Kingdom), A. Wilson (Norwich, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), C. Leonard (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom). Breath Biomarkers in Idiopathic Pulmonary Fibrosis: A Systematic Review. 2921
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Exhaled Breath Biomarkers in Sarcoidosis: A Systematic Review
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
Cardiac MRI for Prognosis in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
Source: Virtual Congress 2020 – Imaging-based phenotyping in pulmonary disease
Year: 2020
Nutritional Supplementation during Pulmonary Rehabilitation in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review
Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases
Year: 2019
Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis?
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Systematic Review and Meta-Analysis of Endoscopic Lung Volume Reduction Using Endobronchial Valves in Severe Emphysema: Are They Better?
Source: International Congress 2018 – General thoracic surgery
Year: 2018
Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary
Source: Guideline 2015
Year: 2015
Aerobic and Breathing Exercises Improve Dyspnea, Exercise Capacity and Quality of Life in Idiopathic Pulmonary Fibrosis Patients: Systematic Review and Meta-Analysis.
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF)
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Treatment of Idiopathic Pulmonary Fibrosis - Evidence to Decision Frameworks
Source: Guideline 2015
Year: 2015
Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – M-health/e-health I
Year: 2019
Book Review: Pulmonary Hypertension
Source: Eur Respir Rev 2012 21: 372
Year: 2012
Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Evaluation of Idiopathic Pulmonary Fibrosis therapies, Pirfenidone and Nintedanib, in a Human Experimental Model of Fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019
Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Treatment of Idiopathic Pulmonary Fibrosis
Source: Guideline 2015
Year: 2015
Epidemiology of Idiopathic Pulmonary Fibrosis in Australia
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept